2026 Interim report
Filed with HKEX · Stock code 2289 · · 147 pages · English and Chinese
創美藥業股份有限公司（「本公司」或「我們」，連同其附屬公司，統稱「 本集團」）（股份代號： 2289.HK）主營醫藥分銷業務，主要向下游分銷商和零售終端分銷西藥、中成藥、保健品等產品，同時也開展第三方物流服務，並提供醫藥產品諮詢服務。本公司創立於 2000 年，經過 26 年的快速發展，已成長為華南地區領先的醫藥分銷商之一。本公司堅持「深耕廣東，輻射周邊」的發展戰略，立足於汕頭，在廣州、珠海、惠州、佛山及深圳成立子公司，並擁有四個現代化醫藥物流中心，專業的營銷服務團隊以及運輸服務團隊，對非招標市場實行「半徑 10 公里內一日三配、50 公里內一日兩配、250 公里內一日一配」的高效配送機制。本公司具有現代化信息系統，涵蓋整個醫藥分銷供應鏈，包括採購、銷售、倉儲、運輸及交付等。本公司同時運營自建的 B2B 電子商務平台：「創美 e 藥」，供客戶線上下單、查詢及支付等。本公司於 2025 年全
Charmacy Pharmaceutical Co., Ltd. on 6ix
Earlier from Charmacy Pharmaceutical
- Exchange notice - trading halt
- Form of proxy for use at the annual general meeting to be held at the conference room on 3rd floor, no. 235 song shan north road, longhu district, shantou city, guangdong province, the prc on 31 May 2021 at 10 a.m. or at any adjournment thereof
- (1) Proposed election of directors of the third session of the board; and (2) proposed election of shareholder representative supervisor and independent supervisor of the third session of the supervisory committee
- Change of building name of principal place of business in hong kong
- Reply slip for the 2020 first H shareholders' class meeting to be held at the conference room on 3rd Floor, no. 235 song shan north road, longhu district, shantou city, guangdong province, the prc, on 20 January 2020 at 11: 00 a.m or any adjournment thereof
Later from Charmacy Pharmaceutical
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Follow Charmacy Pharmaceutical into a list and get an email when it puts out news.
Follow Charmacy Pharmaceutical